PBM
KURA icon

Propel Bio Management’s Kura Oncology KURA Stock Holding History

Propel Bio Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-130,000
Closed -$1.13M – 22
2024
Q4 		$1.13M Hold
130,000
– – 1.12% 14
2024
Q3 		$2.54M Hold
130,000
– – 1.47% 14
2024
Q2 		$2.68M Hold
130,000
– – 1.74% 15
2024
Q1 		$2.77M Hold
130,000
– – 1.61% 13
2023
Q4 		$1.87M Buy
+130,000
New +$1.28M 1.55% 20

Other funds holding KURA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return